Abstract
Cytoreductive surgery is a crucial component of the management of cancer of the ovary. Surgical cytoreduction of ovarian cancer volume has been associated with an increase in survival in all settings in which it has been studied. This association seems strongest, and the benefits of aggressive surgery are generally greatest, in patients with chemosensitive disease. Effective surgical management of ovarian cancer, therefore, requires competence in surgical anatomy and cytoreductive techniques and a thorough understanding of the patient's disease status and therapeutic goals.
| Original language | English |
|---|---|
| Pages (from-to) | 871-883 |
| Number of pages | 13 |
| Journal | Surgical Clinics of North America |
| Volume | 81 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Female
- Humans
- Ovarian Neoplasms/pathology
Fingerprint
Dive into the research topics of 'Cytoreductive surgery for ovarian cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver